Login to Your Account

Genzyme, TKT In Rematch; This Time, Gaucher's Drugs

By Randall Osborne

Monday, January 31, 2005
It's déjà vu with a difference. Genzyme Corp.'s patent lawsuit in Israel - where the patent was filed - against Transkaryotic Therapies Inc. over drugs to treat Gaucher's disease recalls an earlier skirmish (and race to the U.S. market) with therapies for an enzyme-shortage disorder. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription